EET-A [disodium (Z)-(13-(3-pentylureido) tridec-8-enoyl)-l-aspartate], a 14,15-EET analog, was given in drinking water, and its concentration was adjusted in such a way that the daily dose was either 10 mg/kg/day (EET-A) or a high dose of 40 mg/day/kg (EET-A HD). 20-HETE receptor antagonist {disodium [(6Z,15Z)-20-hydroxyeicosa-6,15-dienoyl]-l-aspartate; AAA} was also given in drinking water at a concentration adjusted to yield a daily dose of 10 mg/kg/day, based on our recent studies (Gangadhariah et al., 2014; Sedláková et al., 2018; Gawrys et al., 2020a). The EET-A and AAA were designed and synthesized in the laboratory of JRF.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.